Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 12;72(10):3243–3257. doi: 10.1007/s00262-023-03490-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

In the design of CAR-M, Prof Rong Xiang and Yi Shi from Nankai University have given good suggestions. Sincere acknowledgment to them for their kindly support. Elements used for Fig.2b in this article were downloaded from https://smart.servier.com. The Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License. This work was supported by the Prospective Research Program of the Foundation for the Development of Frontier Technology of Cell Therapy of Changzhou Xitaihu (2022-P-009, Y.L.), the Fundamental Research Funds for the Central Universities (3332022181, Z.D.) and the Bilateral Inter-Governmental S&T Cooperation Project from Ministry of Science and Technology of China (2018YFE0114300, Y.L.).

PMC Copyright notice

Fig.6 — The mmB and mmC displayed enhanced antitumor effects in immunocompetent breast cancer mice model. a Schematic diagram of the experiment. b The weight and picture of tumors. c The weight of livers, lungs and spleens. d Body weight of tumor-bearing mice. e Percentage of macrophages (CD11b⁺F4/80⁺/CD45⁺) in the tumor-infiltrating immune cells. N = 5 mice/group. * P < 0.05, ** P < 0.01